More than 220 organizations, including the AHA, Friday urged Senate committee leaders to consider the Overdose Prevention and Patient Safety Act (H.R. 6082) and encourage Senate leadership to bring the bill to the floor for a vote during the lame-duck session. The House-passed bill would align federal regulations governing the confidentiality of drug and alcohol treatment and prevention records with the Health Insurance Portability and Accountability Act and strengthen consumer protections. “Modifying Part 2 to ensure that HIPAA-covered entities have access to a patient’s medical record will improve patient safety, treatment and outcomes across the care delivery spectrum, enhancing the entire opioid package passed by the House and Senate,” the organizations said in a letter to leaders of the Senate Health, Education, Labor and Pensions Committee.

Headline
In this conversation, three leaders from CommonSpirit Health explore how the organization is confronting stigma about substance use head-on through education,…
Headline
The Health Resources and Services Administration will award grants to rural hospitals and other providers from two areas of its Rural Communities Opioid…
Perspective
Public
May is Mental Health Awareness Month, a time to elevate a conversation that hospitals and health systems live every day. Behavioral health is inseparable from…
Headline
The AHA April 29 urged House and Senate appropriations committee leaders to fund health care programs that have been successful in improving access to care for…
Headline
The AHA submitted a statement for the record to the House Ways and Means Committee for its April 28 hearing with health system CEOs.In the statement, the AHA…
Headline
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18…